KRAS G12C inhibitor 21
This small molecule compound is a selective inhibitor of the KRAS G12C mutant protein. It is used in cancer research to study oncogenic signaling and has demonstrated activity in both cellular assays and in vivo tumor models, supporting its utility as a research tool for targeted therapy development.
Product Specifications
CAS Number
2737269-61-1
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Smiles
O=C1N (C=2C (N (CC3CN (C (C=C) =O) C3) C1=O) =CC (Cl) =C (C2) C=4C5=C (C=C (O) C4) C=CC=C5) C6=C (C (C) C) C=CC=C6
Molecular Formula
C34H30ClN3O4
Molecular Weight
580.07
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940050-500 1x 500 µL
IgA Secretory Component (SC05), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740012-500 1x 500 µL
Tyrosinase (T311), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040034-500 1x 500 µL
Cytokeratin 8/18 (C-51), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940965-500 1x 500 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740050-100 1x 100 µL
IgA Secretory Component (SC05), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400177-100 1x 100 µL
CD50 (ICAM-3) (101-1D2), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details